Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.
Yuan S, Fu Q, Zhao L, Fu X, Li T, Han L, Qin P, Ren Y, Huo M, Li Z, Lu C, Yuan L, Gao Q, Wang Z.
Yuan S, et al. Among authors: li t, li z.
Oncologist. 2022 Jun 8;27(6):e463-e470. doi: 10.1093/oncolo/oyab068.
Oncologist. 2022.
PMID: 35348754
Free PMC article.
Clinical Trial.